Hims & Hers Health, Inc. (HIMS)
NYSE: HIMS · Real-Time Price · USD
27.71
-0.11 (-0.40%)
At close: Sep 4, 2026, 4:00 PM EDT
27.82
+0.11 (0.40%)
After-hours: Sep 4, 2026, 7:59 PM EDT
Hims & Hers Health Stock Forecast
Stock Price Forecast
According to 15 analysts polled by S&P Global, Hims & Hers Health stock has a consensus rating of "Hold" and an average price target of $31.23. The average 1-year stock price forecast is 12.70% higher than the current stock price, while the lowest is $23 (-17.00%) and the highest is $42 (+51.57%).
Price Target: $31.23 (+12.70%)
Analyst Consensus: Hold
Price Target
ChartAnalyst Ratings
The average analyst rating for Hims & Hers Health stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 2 | 3 | 3 | 2 | 2 | 2 |
| Hold | 12 | 12 | 12 | 11 | 12 | 11 |
| Sell | 0 | 0 | 0 | 1 | 0 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 15 | 16 | 16 | 15 | 15 | 15 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Hold Maintains $31 | Hold | Maintains | $31 | +11.87% | Sep 3, 2026 |
| KeyBanc | KeyBanc | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Sep 2, 2026 |
| Truist Financial | Truist Financial | Hold Reiterates $27 → $32 | Hold | Reiterates | $27 → $32 | +15.48% | Aug 24, 2026 |
| Barclays | Barclays | Buy Reiterates $39 → $35 | Buy | Reiterates | $39 → $35 | +26.31% | Aug 21, 2026 |
| Deutsche Bank | Deutsche Bank | Hold Reiterates $25 → $26 | Hold | Reiterates | $25 → $26 | -6.17% | Aug 11, 2026 |
Financial Forecast
Revenue This Year
3.21B
from 2.35B
Increased by 36.63%
Revenue Next Year
3.99B
from 3.21B
Increased by 24.53%
EPS This Year
0.29
from 1.10
Decreased by -73.69%
EPS Next Year
0.76
from 0.29
Increased by 162.99%
EPS and Forward PE are based on non-GAAP adjusted numbers.